Designer disasters, a legacy to leave behind
Stoner Halpern, J.
Disaster Management and Response Dmr An Official Publication of the Emergency Nurses Association 2(3): 65-66
2004
ISSN/ISBN: 0197-2510 PMID: 15286610 Document Number: 571088
Document emailed within 1 workday
Related Documents
Scholz, R.D.; Neumann, H. 1983: Possibilities of reducing sick leave based on the length of leave from occupational accidents and the distribution of sick leave Zeitschrift für Arztliche Fortbildung 77(6): 266-268Foubert, P. 2017: Child Care Leave 2.0 – Suggestions for the improvement of the EU Maternity and Parental Leave Directives from a rights perspective Maastricht Journal of European and Comparative Law 24(2): 245-263
Harnden, L. 1986: Illness related to pregnancy--sick leave or maternity leave? Dimensions in Health Service 63(3): 31; 43
Adger, W.N.; Hughes, T.P.; Folke, C.; Carpenter, S.R.; Rockstrom, J. 2005: Social-ecological resilience to coastal disasters : Dealing with disasters - Protection sociale et écologique contre les catastrophes du littoral : Gestion des catastrophes Science (Washington, D.C.) 309(5737): 1036-1039
Meyer, L.I. 1984: Pregnancy leave. Changed laws on pregnancy leave and daily allowance Sygeplejersken 84(9): 14-15
Naito, H. 2010: Entactogen and designer drugs (2) Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 23(2): 97-104
Mendive, J.M. 1998: The family physician and designer drugs Atencion Primaria 21(3): 180-181
Henderson, F.; Kenny, G.N. 1999: Controversies in anaesthesia--designer drugs Annals of the Academy of Medicine Singapore 28(3): 434-439
Cohen, J. 2000: Designer labs: architecture discovers science Science 287(5451): 210-214
Wollrab, T.I. 1997: Designer "genes": the future of cattle cloning? Journal of the American Veterinary Medical Association 211(8): 960-962
Henderson, G.L. 1988: Designer drugs: past history and future prospects Journal of Forensic Sciences 33(2): 569-575
McKibben, M.A. 1996: Designer drinks and drunkenness among schoolchildren. More "alcopops" have come on marker since study was done Bmj 313(7069): 1397; Author Reply 1397-8
Brüggemann, M.; Davies, N.P.; Rosewell, I.R. 1993: Designer mice: the production of human antibody repertoires in transgenic animals Year in Immunology 7: 33-40
Misselbrook, G.P.; Hamilton, E.J. 2012: Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs Acute Medicine 11(3): 157-160
Wierzejska, R. 2014: Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism Developmental Period Medicine 18(3): 394-399
Hajtó, J.; Marinescu, C.; Silva, N.R.F.A. 2014: Morphogenic designer--an efficient tool to digitally design tooth forms International Journal of Computerized Dentistry 17(3): 219-238
Järvinen, T.; Boyd, J. 2015: Designer-drug overdose patients treated by Helsinki Emergency Medical Services in 2009-2012 Duodecim; laaketieteellinen aikakauskirja 131(18): 1659-1666
O'Malley, P. 2011: The worldwide designer drug craze: bath salts behind the counter to get high: update for the clinical nurse specialist Clinical Nurse Specialist Cns 25(5): 224-225
Mayorov, O.Y. 2000: Virtual training simulator--designer of EEG signals for tutoring students and doctors to methods of quantitative EEG analysis (qEEG) Studies in Health Technology and Informatics 77: 573-577
Milko, M. 2006: What will be our legacy? Michigan Medicine 105(1): 20